|
ANKRD13C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08246744900953E-13 |
| Normal-vs-Stage2 |
2.01119999543309E-08 |
| Normal-vs-Stage3 |
2.21600515715181E-13 |
| Normal-vs-Stage4 |
1.70907732410797E-12 |
| Stage1-vs-Stage2 |
6.604600E-01 |
| Stage1-vs-Stage3 |
1.145610E-01 |
| Stage1-vs-Stage4 |
3.357800E-03 |
| Stage2-vs-Stage3 |
5.157800E-01 |
| Stage2-vs-Stage4 |
1.005830E-01 |
| Stage3-vs-Stage4 |
1.931040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.91963999999212E-05 |
| Normal-vs-Asian |
2.02990002584613E-09 |
| Caucasian-vs-AfricanAmerican |
5.720800E-01 |
| Caucasian-vs-Asian |
8.878000E-01 |
| AfricanAmerican-vs-Asian |
5.492200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49054118942149E-13 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
8.070000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.05400141339851E-11 |
| Normal-vs-Age(41-60Yrs) |
1.92068583260152E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62625468647093E-12 |
| Normal-vs-Age(81-100Yrs) |
4.817800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.049220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.166000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.314600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.555200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.505200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.210000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.588400E-02 |
| Classical-VS-Follicular |
1.700090E-02 |
| Classical-VS-Other |
3.532600E-01 |
| Classical-VS-Normal |
2.30515606602921E-12 |
| Tall-VS-Follicular |
7.510400E-01 |
| Tall-VS-Other |
9.545400E-01 |
| Tall-VS-Normal |
2.78089995475739E-10 |
| Follicular-VS-Other |
9.033800E-01 |
| Follicular-VS-Normal |
3.38162831070576E-12 |
| Other-VS-Normal |
1.182430E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.43849426498855E-15 |
| Normal-vs-N1 |
4.40619762898109E-11 |
| N0-vs-N1 |
6.509800E-01 |
|
|
